Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1977-12-27
1979-07-31
Waltz, Thomas
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
260556A, 260556AR, 260556S, 260559D, 260559S, 260559A, 424321, 424324, C07C10326, C07C14375, A61K 31165, A61K 3118
Patent
active
041630530
ABSTRACT:
5-[2-(Substituted-anilinoalkylamino)-1-hydroxyalkyl]-salicylamides, particularly useful as agents for the treatment of hypertension, are disclosed herein.
REFERENCES:
patent: 3644353 (1972-02-01), Lunts et al.
patent: 3676493 (1972-07-01), Smith
patent: 3723524 (1973-03-01), Augstein et al.
patent: 3816516 (1974-06-01), Cox et al.
patent: 3888898 (1975-06-01), Koppe et al.
patent: 3944611 (1976-03-01), Smith
patent: 3959369 (1976-05-01), Smith
patent: 4000192 (1976-12-01), Lunts et al.
patent: 4000193 (1976-12-01), Lunts et al.
patent: 4012444 (1977-03-01), Lunts et al.
patent: 4086272 (1978-04-01), Cox et al.
Gold Elijah H.
Neustadt Bernard R.
Eisen Bruce M.
Renda Barbara L. Cowley
Schering Corporation
Waltz Thomas
LandOfFree
Anti-hypertensive 5-[2-(substituted anilinoalkylamino)-1-hydroxy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-hypertensive 5-[2-(substituted anilinoalkylamino)-1-hydroxy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-hypertensive 5-[2-(substituted anilinoalkylamino)-1-hydroxy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-23278